Perrigo Company plc ( PRGO) - Stock Earnings
PRGO Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -1.4 billion USD | 1.1 billion USD |
| 2026Q1 | -398.6 million USD | 969.2 million USD |
| 2026Q2 | 74.5 million USD | 1.0 billion USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
PRGO Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -12.7 million USD | 4.7 billion USD |
| 2024 | -171.8 million USD | 4.4 billion USD |
| 2025 | -1.4 billion USD | 4.3 billion USD |
| 2026 Est. | — | — |
PRGO
List: Challengers
Price: $14.92
Dividend Yield: 9.03%
Forward Dividend Yield: 7.77%
Payout Ratio: -133.01%
Dividend Per Share: 1.16 USD
Earnings Per Share: -12.10 USD
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: Ireland
Volume: 680000
Ebitda: 274.7 millionMarket Capitalization: 1.7 billion
Average Dividend Frequency: 4
Years Paying Dividends: 24
DGR3: 6.74%
DGR5: 8.34%
DGR10: 10.70%
DGR20: 11.18%